TY - JOUR
T1 - Recommendations for the use of serious games in neurodegenerative disorders
T2 - 2016 Delphi Panel
AU - Manera, Valeria
AU - Ben-Sadoun, Grégory
AU - Aalbers, Teun
AU - Agopyan, Hovannes
AU - Askenazy, Florence
AU - Benoit, Michel
AU - Bensamoun, David
AU - Bourgeois, Jérémy
AU - Bredin, Jonathan
AU - Bremond, Francois
AU - Crispim-Junior, Carlos
AU - David, Renaud
AU - Schutter, Bob De
AU - Ettore, Eric
AU - Fairchild, Jennifer
AU - Foulon, Pierre
AU - Gazzaley, Adam
AU - Gros, Auriane
AU - Hun, Stéphanie
AU - Knoefel, Frank
AU - Rikkert, Marcel Olde
AU - Phan Tran, Minh K.
AU - Politis, Antonios
AU - Rigaud, Anne S.
AU - Sacco, Guillaume
AU - Serret, Sylvie
AU - Thümmler, Susanne
AU - Welter, Marie L.
AU - Robert, Philippe
N1 - Publisher Copyright:
© 2017 Manera, Ben-Sadoun, Aalbers, Agopyan, Askenazy, Benoit, Bensamoun, Bourgeois, Bredin, Bremond, Crispim-Junior, David, De Schutter, Ettore, Fairchild, Foulon, Gazzaley, Gros, Hun, Knoefel, Olde Rikkert, Phan Tran, Politis, Rigaud, Sacco, Serret, Thümmler, Welter and Robert.
PY - 2017/7/25
Y1 - 2017/7/25
N2 - The use of Serious Games (SG) in the health domain is expanding. In the field of neurodegenerative disorders (ND) such as Alzheimer's disease, SG are currently employed both to support and improve the assessment of different functional and cognitive abilities, and to provide alternative solutions for patients' treatment, stimulation, and rehabilitation. As the field is quite young, recommendations on the use of SG in people with ND are still rare. In 2014 we proposed some initial recommendations (Robert et al., 2014). The aim of the present work was to update them, thanks to opinions gathered by experts in the field during an expert Delphi panel. Results confirmed that SG are adapted to elderly people with mild cognitive impairment (MCI) and dementia, and can be employed for several purposes, including assessment, stimulation, and improving wellbeing, with some differences depending on the population (e.g., physical stimulation may be better suited for people with MCI). SG are more adapted for use with trained caregivers (both at home and in clinical settings), with a frequency ranging from 2 to 4 times a week. Importantly, the target of SG, their frequency of use and the context in which they are played depend on the SG typology (e.g., Exergame, cognitive game), and should be personalized with the help of a clinician.
AB - The use of Serious Games (SG) in the health domain is expanding. In the field of neurodegenerative disorders (ND) such as Alzheimer's disease, SG are currently employed both to support and improve the assessment of different functional and cognitive abilities, and to provide alternative solutions for patients' treatment, stimulation, and rehabilitation. As the field is quite young, recommendations on the use of SG in people with ND are still rare. In 2014 we proposed some initial recommendations (Robert et al., 2014). The aim of the present work was to update them, thanks to opinions gathered by experts in the field during an expert Delphi panel. Results confirmed that SG are adapted to elderly people with mild cognitive impairment (MCI) and dementia, and can be employed for several purposes, including assessment, stimulation, and improving wellbeing, with some differences depending on the population (e.g., physical stimulation may be better suited for people with MCI). SG are more adapted for use with trained caregivers (both at home and in clinical settings), with a frequency ranging from 2 to 4 times a week. Importantly, the target of SG, their frequency of use and the context in which they are played depend on the SG typology (e.g., Exergame, cognitive game), and should be personalized with the help of a clinician.
KW - Delphi technique
KW - ICT
KW - Neurodegenerative disorders
KW - Recommendations
KW - Serious games
UR - http://www.scopus.com/inward/record.url?scp=85026224926&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85026224926&partnerID=8YFLogxK
U2 - 10.3389/fpsyg.2017.01243
DO - 10.3389/fpsyg.2017.01243
M3 - Article
C2 - 28790945
AN - SCOPUS:85026224926
SN - 1664-042X
VL - 8
JO - Frontiers in Physiology
JF - Frontiers in Physiology
IS - JUL
M1 - 1243
ER -